Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

M Pharma completes 40J’s acquisition on schedule

Friday, February 17, 2017 7:19
% of readers think this story is Fact. Add your two cents.

M Pharmaceutical Inc (CNSX:MQ) has successfully closed the acquisition of 40J’s bang on schedule.

The company paid US$300,000 in cash at closing, issued 38,837,000 shares and US$2.5mln in unsecured five-year convertible notes to secure ownership of the assets of Cincinnati-based 40J’s.

The assets include a female sexual dysfunction drug, and menthol and l-arginine patented technology.

M Pharma is also liable for deferred cash payments and possible milestone payments of around $3.45mln and will pay a mid-single digit percentage royalty on sales of the female sexual dysfunction drug once commercialized.

“This is a significant step in the development of M Pharma as a company. This provides us not only with a suite of products that are currently being marketed to the tune of approximately US$800,000 in annual revenue to us now, but we have the basis to develop other applications, including a female dysfunction drug, which will be topical, local and non-systemic, with daily and on demand use, while being non-hormonal and not a central nervous system drug,” said gary Thompson, president and chief executive officer of M Pharma.


Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.